Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vidipha, officially known as Central Pharmaceutical Joint Stock Company No. 2, is a leading pharmaceutical manufacturer in Vietnam with a history dating back to 1976. Headquartered in Ho Chi Minh City, the company specializes in the production and distribution of a wide array of generic drugs, including antibiotics, analgesics, and vitamins. Vidipha operates state-of-the-art manufacturing facilities that are certified for WHO-GMP, GLP, and GSP standards, ensuring high-quality output for both the domestic Vietnamese market and international exports. As a publicly traded company on the Ho Chi Minh City Stock Exchange (HOSE: VDP), it maintains a robust portfolio of over 300 products and is a key supplier to hospitals and pharmacies nationwide. The company continues to expand its manufacturing capacity and product range to meet growing healthcare demands in Southeast Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vidipha Central Pharmaceutical.